#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleural mesothelioma Cushing's syndrome Familial amyotrophic lateral sclerosis Cholangiosarcoma Laryngeal squamous cell carcinoma Bronchopulmonary dysplasia Follicle centre lymphoma follicular grade I II – III refractory Dedifferentiated liposarcoma Cardiac sarcoidosis Ocular lymphoma Hepatitis D B precursor type acute leukaemia Non-small cell lung cancer Andersen-Tawil syndrome Scedosporium infection More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Diagnostics Systemic mastocytosis – Treatment Andersen-Tawil syndrome – Life with Disease Haemophilia B without inhibitors – Basic Information MELAS syndrome – Treatment Marfan’s syndrome Angiosarcoma non-metastatic – Treatment KBG syndrome Leiomyosarcoma metastatic – Diagnostics Methylmalonic acidaemia – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LINAPRAZAN GLURATE ARI0008 Lovo-B Cenobamate Desloratadine Levomepromazine Hydrochloride Cladribine Aavanc80-3'Hotof Micafungin Afimetoran Besilate Dihydrate Bms-986449-03 Rbl007.2 Myrrh Iopromide Pariglasgene Brecaparvovec Atrasentan Hydrochloride Zalunfiban Chlorhexidine Dihydrochloride Copanlisib Dihydrochloride Dl-Alpha-Tocopherol More therapies…

    Learn about Your Condition

    Nodal osteoarthritis Pterygium Endotracheal intubation Venous thrombosis Ventricular extrasystoles Alopecia areata End stage renal disease Essential hypertension Fontan procedure Abdominal infection Lymphangioleiomyomatosis Ventricular fibrillation Lupus nephritis Menopausal symptoms Cardiac disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Istituto Oncologico Veneto

Istituto Oncologico Veneto

Via Gattamelata 64, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Rituximab and Golcadomide for Older Frail Patients with Diffuse Large B-cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Golcadomide
    • Rituximab
    Italy

  • Study on the Effectiveness of Denosumab with Chemotherapy (Cisplatin, Methotrexate, Doxorubicin) for Patients with Metastatic Osteosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma metastatic
    Investigated Drugs:
    • Denosumab
    • Methotrexate
    • Cisplatin
    Italy

  • Study on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Axitinib
    • Lenvatinib
    • Cabozantinib
    Italy

  • Study on Tedopi and Nivolumab for Patients with Advanced Non-Small Cell Lung Cancer After Initial Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • D-Ala-Lys-Cha-Val-Ala-Ala-Trp-Thr-Leu-Lys-Ala-Ala-D-Ala
    • Mps-102
    • Mps-103
    France Italy Spain

  • Study on Letrozole vs. Chemotherapy (Carboplatin and Paclitaxel) for Patients with Advanced Low-Grade Serous Ovarian Cancer with Hormone Receptors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer stage III
    • Ovarian cancer stage IV
    Investigated Drugs:
    • Carboplatin
    • Letrozole
    • Paclitaxel
    Czechia Italy

  • Comparison of Niraparib alone versus Niraparib with Bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Carboplatin
    • Niraparib
    Belgium Czechia Germany Italy

  • Study on the Effectiveness of Gilteritinib and Drug Combination for Patients with Relapsed or Refractory Acute Myeloid Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Amsacrine
    • Gilteritinib
    • Idarubicin Hydrochloride
    Czechia Germany Italy Lithuania Portugal Romania +1

  • Study Comparing Amivantamab and Chemotherapy Versus Cetuximab and Chemotherapy for Patients with Advanced Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Amivantamab
    • Cetuximab
    Belgium France Germany Hungary Italy The Netherlands +3

  • Study of Lutetium (177Lu) Oxodotreotide for Patients with Recurrent Meningioma Without Surgery or Radiotherapy Options

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Octreotide Acetate
    • Hydroxycarbamide
    Austria Denmark France Germany Italy The Netherlands +2

  • Study on Cemiplimab for Patients with High-Risk Stage III/IV Cutaneous Squamous Cell Carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Cemiplimab
    Italy
Previous Page
1 … 8 9 10 11 12 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!